Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123131962 | 12313196 | 2 | F | 201602 | 20160726 | 20160428 | 20160803 | EXP | FR-ASTRAZENECA-2016SE43772 | ASTRAZENECA | 24654.00 | DY | F | Y | 0.00000 | 20160803 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123131962 | 12313196 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | U | U | 206995 | 250 | MG | TABLET | QD | |||||
| 123131962 | 12313196 | 2 | SS | IRESSA | GEFITINIB | 1 | Oral | U | U | 206995 | 250 | MG | TABLET | QD | |||||
| 123131962 | 12313196 | 3 | SS | IRESSA | GEFITINIB | 1 | Oral | U | U | 206995 | .5 | DF | TABLET | QD | |||||
| 123131962 | 12313196 | 4 | SS | IRESSA | GEFITINIB | 1 | Oral | U | U | 206995 | .5 | DF | TABLET | QD | |||||
| 123131962 | 12313196 | 5 | C | INNOHEP | TINZAPARIN SODIUM | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 6 | C | KEPPRA | LEVETIRACETAM | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 7 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 8 | C | SEROPLEX | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 9 | C | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 10 | C | COTAREG | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 11 | C | SIMVASTATINE | SIMVASTATIN | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 12 | C | SPECIAFOLDINE | FOLIC ACID | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 13 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 14 | C | INEXIUM | ESOMEPRAZOLE | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 15 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 16 | C | DOLIPRANE | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 17 | C | CORTANCYL | PREDNISONE | 1 | 0 | ||||||||||||
| 123131962 | 12313196 | 18 | C | LYRICA | PREGABALIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123131962 | 12313196 | 1 | Lung adenocarcinoma |
| 123131962 | 12313196 | 2 | Metastases to central nervous system |
| 123131962 | 12313196 | 3 | Lung adenocarcinoma |
| 123131962 | 12313196 | 4 | Metastases to central nervous system |
| 123131962 | 12313196 | 5 | Phlebitis |
| 123131962 | 12313196 | 6 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123131962 | 12313196 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123131962 | 12313196 | Diarrhoea | |
| 123131962 | 12313196 | Nausea | |
| 123131962 | 12313196 | Off label use | |
| 123131962 | 12313196 | Prerenal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123131962 | 12313196 | 1 | 201602 | 20160404 | 0 | |
| 123131962 | 12313196 | 2 | 201602 | 20160404 | 0 | |
| 123131962 | 12313196 | 3 | 20160407 | 0 | ||
| 123131962 | 12313196 | 4 | 20160407 | 0 |